References
- Abdel-Rafei M, Amin MM, Hasan HF. 2017. Novel effect of Daflon and low-dose gamma-radiation in modulation of thioacetamide-induced hepatic encephalopathy in male albino rats. Hum Exp Toxicol. 36(1):62–81. doi: https://doi.org/10.1177/0960327116637657
- Abwainy A, Babiker F, Akhtar S, Benter IF. 2016. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning. Am J Physiol Heart Circ Physiol. 310(1):H104–H112. eng. doi: https://doi.org/10.1152/ajpheart.00121.2015
- Al-Herz W, Babiker F. 2017. Acute intravenous infusion of immunoglobulins protects against myocardial ischemia-reperfusion injury through inhibition of caspase-3. Cell Physiol Biochem. 42(6):2295–2306. doi: https://doi.org/10.1159/000480002
- Babiker F, Al-Jarallah A, Al-Awadi M. 2019. Effects of cardiac hypertrophy, diabetes, aging, and pregnancy on the cardioprotective effects of postconditioning in male and female rats. Cardiol Res Pract. 2019:3403959. doi: https://doi.org/10.1155/2019/3403959
- Babiker FA, Elkhalifa LA, Moukhyer ME. 2013. Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults. Cardiovasc J Afr. 24(6):208–212. doi: https://doi.org/10.5830/CVJA-2013-035
- Babiker FA, Hoteit LJ, Joseph S, Mustafa AS, Juggi JS. 2012. The role of 17-beta estradiol in ischemic preconditioning protection of the heart. Exp Clin Cardiol. 17(3):95–100. eng.
- Babiker FA, Joseph S, Juggi JS. 2011. What's new in salvage of the ischemic myocardium: estrogen postconditioning. Med Princ Pract Int J Kuwait Univ Health Sci Cent. 20(6):495–496. eng.
- Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, Epelman S, Kreisel D, Liu Y, Itoh A, et al. 2018. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med. 24(8):1234–1245. doi: https://doi.org/10.1038/s41591-018-0059-x
- Banerjee SK, Dinda AK, Manchanda SC, Maulik SK. 2002. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol. 2:16. doi: https://doi.org/10.1186/1471-2210-2-16
- Bellandi F, Maioli M, Gallopin M, Toso A, Dabizzi RP. 2004. Increase of myocardial salvage and left ventricular function recovery with intracoronary Abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv. 62(2):186–192. doi: https://doi.org/10.1002/ccd.20041
- Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al. 2019. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 139(10):e56–e528. doi: https://doi.org/10.1161/CIR.0000000000000659
- Boisseau MR. 2007. Leukocyte involvement in the signs and symptoms of chronic venous disease. Perspectives for therapy. Clin Hemorheol Microcirc. 37(3):277–290.
- Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA, NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia. 2004. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res. 95(2):125–134. doi: https://doi.org/10.1161/01.RES.0000137171.97172.d7
- Braunersreuther V, Jaquet V. 2012. Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr Pharm Biotechnol. 13(1):97–114. doi: https://doi.org/10.2174/138920112798868782
- Burgoyne JR, Oka S, Ale-Agha N, Eaton P. 2013. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal. 18(9):1042–1052. doi: https://doi.org/10.1089/ars.2012.4817
- Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S, Investigators CS. 2002. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 39(1):30–36. doi: https://doi.org/10.1016/S0735-1097(01)01711-9
- Cadenas S. 2018. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med. 117:76–89. doi: https://doi.org/10.1016/j.freeradbiomed.2018.01.024
- Canty JM Jr, Suzuki G. 2012. Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease. J Mol Cell Cardiol. 52(4):822–831. doi: https://doi.org/10.1016/j.yjmcc.2011.08.019
- Cassar A, Holmes DR, Jr, Rihal CS, Gersh BJ. 2009. Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 84(12):1130–1146. doi: https://doi.org/10.4065/mcp.2009.0391
- Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T, Li J. 2018. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-kappaB pathway. Metabolism. 83:256–270. doi: https://doi.org/10.1016/j.metabol.2018.03.004
- Dare AJ, Logan A, Prime TA, Rogatti S, Goddard M, Bolton EM, Bradley JA, Pettigrew GJ, Murphy MP, Saeb-Parsy K. 2015. The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model. J Heart Lung Transplant. 34(11):1471–1480. eng. doi: https://doi.org/10.1016/j.healun.2015.05.007
- D'Autreaux B, Toledano MB. 2007. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 8(10):813–824. doi: https://doi.org/10.1038/nrm2256
- Delbarre B, Delbarre G, Calinon F. 1995. Effect of Daflon 500 mg, a flavonoid drug, on neurological signs, levels of free radicals and electroretinogram in the gerbil after ischemia-reperfusion injury. Int J Microcirc Clin Exp. 15(Suppl 1):27–33. doi: https://doi.org/10.1159/000179092
- de Souza M, Cyrino FZ, Mayall MR, Virgini-Magalhaes CE, Sicuro FL, Carvalho JJ, Verbeuren TJ, Bouskela E. 2016. Beneficial effects of the micronized purified flavonoid fraction (MPFF, daflon(R) 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology. 31(1):50–56. eng. doi: https://doi.org/10.1177/0268355514564414
- Dinarello CA. 2000. Proinflammatory cytokines. Chest. 118(2):503–508. doi: https://doi.org/10.1378/chest.118.2.503
- Erel O. 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 37(4):277–285. doi: https://doi.org/10.1016/j.clinbiochem.2003.11.015
- Erel O. 2005. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 38(12):1103–1111. doi: https://doi.org/10.1016/j.clinbiochem.2005.08.008
- Ferrera R, Benhabbouche S, Bopassa JC, Li B, Ovize M. 2009. One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. Cardiovasc Drugs Ther. 23(4):327–331. doi: https://doi.org/10.1007/s10557-009-6176-5
- Gersh BJ, Stone GW, White HD, Holmes DR Jr. 2005. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA. 293(8):979–986. doi: https://doi.org/10.1001/jama.293.8.979
- Halliwell B, Rafter J, Jenner A. 2005. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr. 81(1 Suppl):268S–276S. doi: https://doi.org/10.1093/ajcn/81.1.268S
- Hausenloy DJ, Yellon DM. 2013. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 123(1):92–100. doi: https://doi.org/10.1172/JCI62874
- Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, Hucker WJ, Wulfers EM, Seemann G, Courties G, et al. 2017. Macrophages facilitate electrical conduction in the heart. Cell. 169(3):510–522.e520. doi: https://doi.org/10.1016/j.cell.2017.03.050
- Jong WM, Ten Cate H, Linnenbank AC, de Boer OJ, Reitsma PH, de Winter RJ, Zuurbier CJ. 2016. Reduced acute myocardial ischemia-reperfusion injury in IL-6-deficient mice employing a closed-chest model. Inflamm Res. 65(6):489–499. doi: https://doi.org/10.1007/s00011-016-0931-4
- Juggi JS, Hoteit LJ, Babiker FA, Joseph S, Mustafa AS. 2011. Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage. Exp Clin Cardiol. 16(2):e5–e10. eng.
- Khalaf A, Babiker F. 2016. Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury. J Physiol Biochem. 72(3):495–508. doi: https://doi.org/10.1007/s13105-016-0498-0
- Kobo PI, Ayo JO, Aluwong T, Zezi AU, Maikai V, Ambali SF. 2014. Flavonoid mixture ameliorates increase in erythrocyte osmotic fragility and malondialdehyde concentration induced by Trypanosoma brucei brucei-infection in Wistar rats. Res Vet Sci. 96(1):139–142. eng. doi: https://doi.org/10.1016/j.rvsc.2013.10.005
- Levraut J, Iwase H, Shao ZH, Vanden Hoek TL, Schumacker PT. 2003. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol. 284(2):H549–H558. doi: https://doi.org/10.1152/ajpheart.00708.2002
- Lim SH. 2017. Larch arabinogalactan attenuates myocardial injury by inhibiting apoptotic cascades in a rat model of ischemia-reperfusion. J Med Food. 20(7):691–699. doi: https://doi.org/10.1089/jmf.2016.3886
- Liu H, Li S, Jiang W, Li Y. 2019. MiR-484 protects rat myocardial cells from ischemia-reperfusion injury by inhibiting caspase-3 and caspase-9 during apoptosis. Korean Circ J. 50(3):250–263. doi: https://doi.org/10.4070/kcj.2019.0107
- Loyer X, Zlatanova I, Devue C, Yin M, Howangyin KY, Klaihmon P, Guerin CL, Kheloufi M, Vilar J, Zannis K, et al. 2018. Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction. Circ Res. 123(1):100–106. doi: https://doi.org/10.1161/CIRCRESAHA.117.311326
- Lyseng-Williamson KA, Perry CM. 2003. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 63(1):71–100. doi: https://doi.org/10.2165/00003495-200363010-00005
- Marquez Loza A, Elias V, Wong CP, Ho E, Bermudez M, Magnusson KR. 2017. Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging. Neuroscience. 344:276–292. doi: https://doi.org/10.1016/j.neuroscience.2016.12.041
- Mulvihill NT, Foley JB. 2002. Inflammation in acute coronary syndromes. Heart. 87(3):201–204. doi: https://doi.org/10.1136/heart.87.3.201
- Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. . Am J Clin Nutr. 74(4):418–425. eng. doi: https://doi.org/10.1093/ajcn/74.4.418
- Pagliaro P, Penna C. 2015. Redox signalling and cardioprotection: translatability and mechanism. Br J Pharmacol. 172(8):1974–1995. doi: https://doi.org/10.1111/bph.12975
- Palazzo AL, Evensen E, Huang YW, Cesano A, Nolan GP, Fantl WJ. 2011. Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells. PloS one. 6(10):e24592. doi: https://doi.org/10.1371/journal.pone.0024592
- Penna C, Mancardi D, Rastaldo R, Pagliaro P. 2009. Cardioprotection: a radical view free radicals in pre and postconditioning. Biochim Biophys Acta. 1787(7):781–793. doi: https://doi.org/10.1016/j.bbabio.2009.02.008
- Raffetto JD., Eberhardt RT., Dean SM., Ligi D., Mannello F. 2016. Pharmacologic treatment to improve venous leg ulcer healing. J Vascular Surg Venous Lymphat Disord. 4(3):371–374. english. doi: https://doi.org/10.1016/j.jvsv.2015.10.002
- Ramelet AA. 2001. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency [Review]. Angiology. 52(Suppl 1):S49–S56. eng. doi: https://doi.org/10.1177/0003319701052001S07
- Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, Thuren T, Group CPI. 2012. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 126(23):2739–2748. doi: https://doi.org/10.1161/CIRCULATIONAHA.112.122556
- Shah S, Mohan M, Kasture S, Ballero M, Maxia A, Sanna C. 2013. Protective effect of Hypericum hircinum on doxorubicin-induced cardiotoxicity in rats. Nat Prod Res. 27(16):1502–1507. doi: https://doi.org/10.1080/14786419.2012.724409
- Sirlak M, Akar AR, Eryilmaz S, Cetinkanat EK, Ozcinar E, Kaya B, Elhan AH, Ozyurda U. 2010. Micronized purified flavonoid fraction in pretreating CABG patients. Tex Heart Inst J. 37(2):172–177.
- Sugamura K, Keaney JF Jr. 2011. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 51(5):978–992. doi: https://doi.org/10.1016/j.freeradbiomed.2011.05.004
- Suzuki K. 2009. Anti-oxidants for therapeutic use: why are only a few drugs in clinical use? [Review]. Adv Drug Deliv Rev. 61(4):287–289. eng. doi: https://doi.org/10.1016/j.addr.2009.03.002
- Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH. 2001. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation. 104(12 Suppl 1):I308–I303. doi: https://doi.org/10.1161/hc37t1.094871
- Techapiesancharoenkij N, Fiala JL, Navasumrit P, Croy RG, Wogan GN, Groopman JD, Ruchirawat M, Essigmann JM. 2015. Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1. Toxicol Appl Pharmacol. 282(1):52–60. doi: https://doi.org/10.1016/j.taap.2014.11.004
- Trommer H, Neubert RH. 2005. The examination of polysaccharides as potential antioxidative compounds for topical administration using a lipid model system. Int J Pharm. 298(1):153–163. doi: https://doi.org/10.1016/j.ijpharm.2005.04.024
- Unlu A, Sucu N, Tamer L, Coskun B, Yucebilgic G, Ercan B, Gul A, Dikmengil M, Atik U. 2003. Effects of Daflon on oxidative stress induced by hindlimb ischemia/reperfusion. Pharmacol Res. 48(1):11–15.
- Yu M, Wen N, Wenzhong Z, Yuanchang X, Xiaoming D, Yongjin L. 2010. Effect of repeated ischaemic preconditioning on TLR4 and proinflammatory cytokines TNF-alpha and IL-1beta in myocardial ischaemia-reperfusion injury in a rat model. Arch Med Sci. 6(6):843–847. doi: https://doi.org/10.5114/aoms.2010.19289
- Zhang ML, Li ZP, Xiao H. 2007. [Different expressions of inflammatory cytokines in two types of cardiac hypertrophy in rats]. Beijing da Xue Xue Bao Yi Xue Ban = J Peking Univ Health Sci. 39(6):570–575.
- Zhang W, Xing B, Yang L, Shi J, Zhou X. 2015. Icaritin attenuates myocardial ischemia and reperfusion injury via anti-inflammatory and anti-oxidative stress effects in rats. Am J Chin Med. 43(6):1083–1097. doi: https://doi.org/10.1142/S0192415X15500627